Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142844 · ClinicalTrials.gov registry record · Phase 2
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
A Phase 2 study of Alcoholism and Cocaine-Related Disorders, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT00142844 is a Phase 2 study of Alcoholism and Cocaine-Related Disorders that has completed, run by University of Pennsylvania. The registered enrollment target is 208 participants, below the 372-participant average among 65 other Alcoholism trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00142844, a Phase 2 study of Alcoholism and Cocaine-Related Disorders, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Many cocaine dependent individuals are also dependent on alcohol. Such individuals respond poorly to existing treatments and have received little research attention in the past. The purpose of this study is to determine whether the combination of naltrexone and disulfiram is useful in decreasing alcohol use and cravings in people diagnosed with both cocaine and alcohol dependence.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naltrexone
- DRUG Disulfiram
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 1999-09 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00142844
The ClinicalTrials.gov registry entry for NCT00142844 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 372-participant average among 65 other Alcoholism trials with a reported enrollment target (44% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alcoholism appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00142844 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00142844 about?
NCT00142844 is a clinical study titled "Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1". Many cocaine dependent individuals are also dependent on alcohol. Such individuals respond poorly to existing treatments and have received little research attention in the past. The purpose of this study is to determine whether the combination of naltrexone and disulfiram is useful in decreasing alc...
What is the current status of trial NCT00142844?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 208 participants. The study started on 1999-09. Estimated completion is 2008-01.
What conditions does trial NCT00142844 study?
This clinical trial studies the following conditions: Alcoholism, Cocaine-Related Disorders, Alcohol-Related Disorders.
What interventions are being tested in trial NCT00142844?
The interventions under investigation include: Placebo (DRUG), Naltrexone (DRUG), Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00142844?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00142844 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Ibudilast for Treating Alcohol Use Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Gabapentin Treatment of Alcohol Dependence
COMPLETED · Phase 2
-
A Study of LY2940094 in Participants With Alcohol Dependency
COMPLETED · Phase 2
-
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
COMPLETED · Phase 2
-
Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.